Share this
Blog
Shared commitment to ensuring patients receive the medicines they need when and where they are needed
Every Cure submitted a formal response to the FDA's Request for Information (RFI) on Drug Repurposing for Unmet Medical Needs (Docket No. FDA-2026-N-4492).
Every Cure is deeply grateful to Giorgos Tsetis for his partnership and generous donation to our mission.
Every year, millions of patients suffer from diseases that lack effective treatments… Share this
Set to enter hospice care, a patient with idiopathic multicentric Castleman’s disease is now in remission after treatment with a medication predicated as the top
In this blog, we highlight the potential role that calcium folinate may play in improving verbal communication in some individuals with speech challenges and certain
We are excited to bring you our newest patient documentary about Kaila, a rare disease patient whose life was saved thanks to a repurposed drug
Every Cure was excited to announce our 3 year, 48.3M contract with ARPA-H at the White House! The ARPA-H contract is aimed to develop our
On this Rare Disease Day, we are highlighting Madison, a patient diagnosed with a rare form of leukodystrophy (LBSL) who is fighting for her ability
On September 23rd, Every Cure Co-Founder David Fajgenbaum addressed Chan Zuckerberg Initiative’s Rare as One Network at the Science in Society Annual Meeting about the
Imagine feeling like you’ve contracted the flu, only to fall into a coma three days later. This was Gary’s reality, an experience he describes as
In a recent address to the Rare Disease Congressional Caucus, David Fajgenbaum, the co-founder of Every Cure, unveiled the organization’s mission to repurposing FDA-approved drugs
Every Cure has raised significant awareness over the last year and engaged with leaders across healthcare and government. In fact, Every Cure Co-Founders Grant Mitchell
President Biden found a copy of the book “Chasing My Cure” on his desk, a gift from none other than former President Clinton. Share this
